Back to User profile » Dr Yanqun Xiang
Papers published by Dr Yanqun Xiang:
Efficacy and Safety of Re-Challenging PD-1 Inhibitors in Second-Line Treatment in Metastatic Nasopharyngeal Carcinoma Previously Treated with Chemotherapy and PD-1 Inhibitors
Bei W, Dong S, Liu G, Lin L, Jiang Y, Lu N, Li W, Liang H, Xiang Y, Xia W
Cancer Management and Research 2024, 16:771-780
Published Date: 10 July 2024
Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
Lv SH, Li WZ, Liang H, Liu GY, Xia WX, Xiang YQ
Journal of Inflammation Research 2021, 14:2225-2237
Published Date: 25 May 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A Scoring System Based on Nutritional and Inflammatory Parameters to Predict the Efficacy of First-Line Chemotherapy and Survival Outcomes for De Novo Metastatic Nasopharyngeal Carcinoma
Li WZ, Hua X, Lv SH, Liang H, Liu GY, Lu N, Bei WX, Xia WX, Xiang YQ
Journal of Inflammation Research 2021, 14:817-828
Published Date: 10 March 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
Xia WX, Liang H, Lv X, Wang L, Ye YF, Ke LR, Xu LH, Guo X, Xiang YQ
Cancer Management and Research 2019, 11:9813-9827
Published Date: 20 November 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
Yu Y, Ke L, Lv X, Ling Y, Lu J, Liang H, Qiu W, Huang X, Liu G, Li W, Guo X, Xia W, Xiang Y
Cancer Management and Research 2018, 10:1935-1946
Published Date: 9 July 2018